A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Primary Research, Independent Perspective, & Objective Analysis
Latest Reports Latest NewsLatest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 401
Comprehensive Pages
- 42
Competitor Profiles
- 11
IOL Categories Forecasted
- 8
Geographic/Economic Breakouts
2021 IOL Market Report: Global Analysis for 2020 to 2026, April, 2021
The “2021 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs.
Latest Industry News & Trends
7/30/2021
BreakingDry EyeGlaucomaIOLRetinaRevenue
Q2-2021 Ophthalmic Revenue Roundup: Novartis, Roche, Hoya, Lumibird
Novartis reported July 21 that its Q2-2021 ophthalmology revenue totaled $1.1 billion, a 19 percent increase from $937 million in pandemic-impacted Q2-2020. Lucentis revenue outside the US in Q2-20...
7/30/2021
BreakingClinical TrialGene TherapyRetina
Adverum Drops ADVM-022 Gene Therapy Candidate in DME Over Safety Issues
Adverum Biotechnologies reported July 22 thatit no longer plans to develop ADVM-022 for diabetic macular edema (DME) and will focus on low-dose use in wet age-related macular degeneration (AMD), ba...
7/30/2021
BreakingCataractDealsPharma
Harrow Acquires Rights to Candidate for Ocular Surface Anesthesia
Harrow Health reported July 27 that it had agreed to acquire the US and Canadian marketing and supply rights to Sintetica’s AMP-100 (chloroprocaine 3% gel), a drug candidate intended to provide ocu...
7/30/2021
BreakingClinical TrialPharmaRetina
Enrollment Begins in Phase I Trial for Shanghai Henlius’ Ophthalmic Bevacizumab Biosimilar
China’s Shanghai Henlius Biotech announced July 19 that the first patient had been dosed in its Phase I trial in China for HLX04-O in wet age-related macular degeneration (AMD). HLX04-O as an ophth...
7/30/2021
BreakingClinical TrialDeviceRetina
LumiThera Shares Positive Data from Pilot Study of Photobiomodulation’s Effect on ERG Outcomes
LumiThera, maker of the Valeda photobiomodulation (PBM) system, reported the final topline data on July 21 from its ELECTROLIGHT pilot study in intermediate dry age-related macular degeneration (AM...
7/30/2021
BreakingDealsPharmaRetina
Ocular Therapeutix, Mosaic Biosciences Collaborate on New Targets for Dry AMD
Ocular Therapeutix has entered into a discovery collaboration with Mosaic Biosciences, of Boulder, Colorado, to identify new targets and therapeutic agents aimed at the treatment of dry age-related...
7/30/2021
BreakingDealsRetina
NGM, Merck Narrow Collaboration to Focus on Retinal, CVM Diseases
NGM Biopharmaceuticals announced July 1 that it had amended its agreement with Merck to extend the companies’ ongoing collaboration through March 2024 but with a narrower scope. The collaboration w...
7/30/2021
BreakingGene TherapyGlaucoma
Arctic Vision to Collaborate with Hong Kong Professor on Neuroprotection for Glaucoma
Chinese company Arctic Vision announced July 4 a new research collaboration with Professor Christopher Leung, head of the Department of Ophthalmology of the University of Hong Kong, for the discove...
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayMarket Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.